Literature DB >> 9327723

Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice.

Y Hoshii1, H Kawano, D Cui, T Takeda, T Gondo, M Takahashi, K Kogishi, K Higuchi, T Ishihara.   

Abstract

Apolipoprotein E (apoE) is a constituent of lipoproteins other than low-density lipoprotein, and it principally acts in the transport and metabolism of plasma cholesterol and triglyceride. ApoE is a minor constituent of various kinds of amyloidoses and may play a role as a pathological chaperone for fibrillogenesis of amyloid fibril protein with the amyloid P component and proteoglycans. In this study, we examined the role of apoE in amyloidogenesis in vivo in apoE-deficient mutant mice with amyloid A protein (AA) amyloidosis induced by inflammatory stimulation. Amyloid deposition was seen in six of nine C57BL/6J control mice and in six of eight apoE-deficient mutant mice after the intraperitoneal and subcutaneous injections of the mixture of complete Freund's adjuvant and Mycobacterium butyricum. Moreover, amyloid deposition in apoE-deficient mice as well as C57BL/6J control mice started 48 or 72 hours after injection of amyloid-enhancing factor and silver nitrate, although the amount of amyloid deposit in C57BL/6J control mice was slightly larger than that in apoE-deficient mice. These amyloid deposits reacted with anti-mouse AA antibody were seen in the perifollicular area of the spleen. Immunoreactivity of apoE was seen irregularly in the amyloid deposits of C57BL/6J control mice but not in the amyloid deposit of apoE-deficient mice. From these results, we concluded that apoE is not always necessary for amyloid deposition and that the existence of apoE might slightly accelerate AA amyloid deposition in the earliest phase of AA amyloid deposition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327723      PMCID: PMC1858060     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Purification and characterization of a senile amyloid-related antigenic substance (apoSASSAM) from mouse serum. apoSASSAM is an apoA-II apolipoprotein of mouse high density lipoproteins.

Authors:  K Higuchi; T Yonezu; K Kogishi; A Matsumura; S Takeshita; K Higuchi; A Kohno; M Matsushita; M Hosokawa; T Takeda
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

2.  Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids.

Authors:  T Kitamoto; K Ogomori; J Tateishi; S B Prusiner
Journal:  Lab Invest       Date:  1987-08       Impact factor: 5.662

3.  Amyloid. 3. A method for rapid induction of amyloidosis in mice.

Authors:  J S Ram; R A DeLellis; G G Glenner
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

4.  Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.

Authors:  K Ishii; A Tamaoka; H Mizusawa; S Shoji; T Ohtake; P E Fraser; H Takahashi; S Tsuji; M Gearing; T Mizutani; S Yamada; M Kato; P H St George-Hyslop; S S Mirra; H Mori
Journal:  Brain Res       Date:  1997-02-14       Impact factor: 3.252

5.  Sandwich enzyme-linked immunosorbent assay of rat apolipoprotein E.

Authors:  H Chiba; T Mitamura; H Matsumiya
Journal:  Biochem Med Metab Biol       Date:  1990-02

6.  Apolipoprotein E is associated with islet amyloid and other amyloidoses: implications for Alzheimer's disease.

Authors:  S B Chargé; M M Esiri; C A Bethune; B C Hansen; A Clark
Journal:  J Pathol       Date:  1996-08       Impact factor: 7.996

7.  Evolution of apolipoprotein E: mouse sequence and evidence for an 11-nucleotide ancestral unit.

Authors:  T B Rajavashisth; J S Kaptein; K L Reue; A J Lusis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

Review 8.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

Authors:  R W Mahley
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

9.  In vitro formation of amyloid fibrils from intact beta 2-microglobulin.

Authors:  L H Connors; T Shirahama; M Skinner; A Fenves; A S Cohen
Journal:  Biochem Biophys Res Commun       Date:  1985-09-30       Impact factor: 3.575

10.  Sulfated glycosaminoglycans: a common constituent of all amyloids?

Authors:  A D Snow; J Willmer; R Kisilevsky
Journal:  Lab Invest       Date:  1987-01       Impact factor: 5.662

View more
  5 in total

1.  Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice.

Authors:  M S Kindy; D J Rader
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

Review 2.  The pathogenesis of amyloidosis: understanding general principles.

Authors:  P Westermark
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

3.  Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid beta-peptide with the N-terminal, receptor binding domain of apolipoprotein E.

Authors:  A A Golabek; E Kida; M Walus; C Perez; T Wisniewski; C Soto
Journal:  Biophys J       Date:  2000-08       Impact factor: 4.033

4.  Inactivation of amyloid-enhancing factor (AEF): study on experimental murine AA amyloidosis.

Authors:  Masatoshi Omoto; Tadaaki Yokota; Dan Cui; Yoshinobu Hoshii; Hiroo Kawano; Toshikazu Gondo; Tokuhiro Ishihara; Takashi Kanda
Journal:  Med Mol Morphol       Date:  2007-06-18       Impact factor: 2.309

5.  Proteomic analysis of highly prevalent amyloid A amyloidosis endemic to endangered island foxes.

Authors:  Patricia M Gaffney; Denise M Imai; Deana L Clifford; Majid Ghassemian; Roman Sasik; Aaron N Chang; Timothy D O'Brien; Judith Coppinger; Margarita Trejo; Eliezer Masliah; Linda Munson; Christina Sigurdson
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.